BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,131,000 | -51.9% | 144,476 | -44.1% | 0.16% | -22.2% |
| Q4 2021 | $35,623,000 | +2.5% | 258,497 | +3.3% | 0.20% | +12.8% |
| Q3 2021 | $34,745,000 | +43.0% | 250,126 | -0.0% | 0.18% | +51.3% |
| Q2 2021 | $24,293,000 | +34.9% | 250,238 | -5.0% | 0.12% | +22.7% |
| Q1 2021 | $18,005,000 | +107.4% | 263,420 | +160.0% | 0.10% | +125.6% |
| Q4 2020 | $8,683,000 | +31.2% | 101,307 | -0.5% | 0.04% | +4.9% |
| Q3 2020 | $6,616,000 | -11.6% | 101,771 | -0.6% | 0.04% | -30.5% |
| Q2 2020 | $7,483,000 | +115.3% | 102,352 | +0.2% | 0.06% | +40.5% |
| Q1 2020 | $3,476,000 | +24.6% | 102,159 | +36.9% | 0.04% | +7.7% |
| Q3 2017 | $2,790,000 | +44.6% | 74,637 | -3.3% | 0.04% | +34.5% |
| Q2 2017 | $1,929,000 | – | 77,169 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |